Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.32-0.34 for the period, compared to the consensus earnings per share estimate of $0.37. The company issued revenue guidance of $247-251 million, compared to the consensus revenue estimate of $258.33 million. Definitive Healthcare also updated its FY 2024 guidance to 0.320-0.340 EPS.
Definitive Healthcare Stock Down 3.9 %
Shares of NASDAQ DH traded down $0.23 during trading hours on Tuesday, hitting $5.74. The company had a trading volume of 3,696,056 shares, compared to its average volume of 710,079. The stock has a market capitalization of $676.92 million, a P/E ratio of -3.28, a price-to-earnings-growth ratio of 4.36 and a beta of 1.30. The company has a quick ratio of 2.30, a current ratio of 2.30 and a debt-to-equity ratio of 0.20. Definitive Healthcare has a 1-year low of $4.38 and a 1-year high of $11.97. The firm’s 50 day moving average is $5.55 and its 200-day moving average is $7.17.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.04). The company had revenue of $63.48 million during the quarter, compared to analyst estimates of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. On average, analysts expect that Definitive Healthcare will post 0.1 earnings per share for the current fiscal year.
Analyst Ratings Changes
Check Out Our Latest Report on DH
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Stories
- Five stocks we like better than Definitive Healthcare
- Best Stocks Under $5.00
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.